MALAT1 and NEAT1, whose upregulation in SARS-CoV-2 infected cell lines and in BALF from COVID-19 patients was discussed earlier, also stand out in the comparative analysis of severe vs. non-severe cases. This evidence concerns the gene MALAT1 and COVID-19.